DermTech, Inc. - Common Stock (DMTK)
0.0940
0.00 (0.00%)
Previous Close | 0.0940 |
---|---|
Open | - |
Bid | 0.0930 |
Ask | 0.0950 |
Day's Range | N/A - N/A |
52 Week Range | 0.0875 - 1.400 |
Volume | 0 |
Market Cap | 2.81M |
PE Ratio (TTM) | -0.0351 |
EPS (TTM) | -2.7 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | - |
News & Press Releases
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!
Via InvestorPlace · June 26, 2024
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
Via InvestorPlace · June 25, 2024
![](https://investorplace.com/wp-content/uploads/2022/08/dna_ginkobioworks1600.png)
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week.
Via InvestorPlace · June 24, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/nktx_cancerresearch1600-1024x576.png)
G1 Therapeutics stock is down on Monday as GTHX investors react to the company's Phase 3 clinical trial of trilaciclib failing.
Via InvestorPlace · June 24, 2024
![](https://investorplace.com/wp-content/uploads/2021/01/delisted-stocks-1600.jpg)
DermTech stock is down on Monday as investors prepare for shares of DMTK to be delisted from the Nasdaq Exchange later this week.
Via InvestorPlace · June 24, 2024
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning!
Via InvestorPlace · June 24, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/21/movers-image_12.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 21, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/21/Movers.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 21, 2024
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via InvestorPlace · June 21, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/20/xrdDAFl-HSvCpE2-j6755793051000407071-t23_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 20, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 19, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 19, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/18/Wall-Street--US-stocks.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 18, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/18/Movers_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 18, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 18, 2024
![](https://mms.businesswire.com/media/20240618662927/en/1859277/22/DMTK_Logo.jpg)
DermTech, Inc. (NASDAQDMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders and maximize the value of its assets.
By DermTech, Inc. · Via Business Wire · June 18, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/23/Nvidia.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 23, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 23, 2024